
Ind-Swift Laboratories has agreed to sell its Active Pharmaceuticals Ingredients (API) business to PI Industries on a slump sale basis, both the companies said in exchange notifications.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rIO2NL
via
IFTTT
0 comments:
Post a Comment